Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma

Wang,Wei‑Ming; Zhao,Zhi‑Li; Zhang,Wen‑Feng; Zhao,Yi‑Fang; Zhang,Lu; Sun,Zhi‑Jun

doi:10.3892/mmr.2015.3815

Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma

Authors:
- Wei‑Ming Wang
- Zhi‑Li Zhao
- Wen‑Feng Zhang
- Yi‑Fang Zhao
- Lu Zhang
- Zhi‑Jun Sun
View Affiliations

Affiliations: The State Key Laboratory Breeding Base of Basic Science of Stomatology and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei 430079, P.R. China
Published online on: May 22, 2015 https://doi.org/10.3892/mmr.2015.3815
Pages: 3432-3438
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adenoid cystic carcinoma (AdCC) of the salivary gland in the head and neck is characterized by indolent yet persistent growth, multiple local recurrences and early hematogenous metastasis. Considering the possible association between the epidermal growth factor receptor (EGFR) signaling pathway and angiogenesis in various types of cancer and the overexpression of EGFR in AdCC, it is reasonable to examine the correlation between angiogenesis and the EGFR signaling pathway in this carcinoma. In the present study, the expression of EGFR, CD31, CD146 and hypoxia‑inducible factor‑1α (HIF‑1α) were evaluated by immunohistochemical staining with tissue microarray containing normal salivary gland (NSG), pleomorphic adenoma (PMA) and AdCC tissues. Pearson's correlation coefficient was conducted to demonstrate the correlation between EGFR, CD31, CD146 and HIF‑1α. To determine their similarity and intimacy, hierarchical analysis was performed with Cluster 3.0 and then visualized using TreeView software. Immunohistochemical results of tissue microarrays were quantified, revealing that the expression of EGFR, CD146 and HIF‑1α increased in AdCC compared with in PMA and NSG tissues. The association between the expression of EGFR and CD31 was significant and positive. The expression of CD146 and HIF‑1α was positively correlated with EGFR and CD31, respectively. These findings suggest that the EGFR signaling pathway has a vital role in AdCC progression and may be associated with HIF‑1α‑mediated angiogenesis. These results may enhance our understanding of the mechanism underlying AdCC progression and provide potential clinical therapeutic strategies based on the inhibition of EGFR.

View Figures

View References

1	Ellington CL, Goodman M, Kono SA, Grist W, Wadsworth T, et al: Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973–2007 surveillance, epidemiology and end results data. Cancer. 118:4444–4451. 2012. View Article : Google Scholar : PubMed/NCBI
2	Bhayani MK, Yener M, El-Naggar A, Garden A, Hanna EY, et al: Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer. 118:2872–2878. 2012. View Article : Google Scholar
3	Laurie SA, Ho AL, Fury MG, Sherman E and Pfister DG: Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: A systematic review. Lancet Oncol. 12:815–824. 2011. View Article : Google Scholar
4	Fantin VR and Abraham RT: Self-eating limits EGFR-dependent tumor growth. Cell. 154:1184–1186. 2013. View Article : Google Scholar : PubMed/NCBI
5	Kitano H, Chung JY, Ylaya K, Conway C, Takikita M, et al: Profiling of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small cell lung cancer. J Histochem Cytochem. 62:335–346. 2014. View Article : Google Scholar : PubMed/NCBI
6	Wu M, Yuan Y, Pan YY and Zhang Y: Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Mol Med Rep. 10:931–938. 2014.PubMed/NCBI
7	Wu M, Yuan Y, Pan YY and Zhang Y: Antitumor activity of combination treatment with gefitinib and docetaxel in EGFR-TKI-sensitive, primary resistant and acquired resistant human non-small cell lung cancer cells. Mol Med Rep. 9:2417–2422. 2014.PubMed/NCBI
8	Fan QW, Cheng CK, Gustafson WC, Charron E, Zipper P, et al: EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell. 24:438–449. 2013. View Article : Google Scholar : PubMed/NCBI
9	Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
10	Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, et al: Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 156:1363–1380. 2000. View Article : Google Scholar : PubMed/NCBI
11	Goel S, Duda DG, Xu L, Munn LL, Boucher Y, et al: Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 91:1071–1121. 2011. View Article : Google Scholar : PubMed/NCBI
12	Garcia S1, Dalès JP and Charafe-Jauffret E: Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum Pathol. 38:830–841. 2007. View Article : Google Scholar : PubMed/NCBI
13	Stopp S, Bornhauser M, Ugarte F, Wobus M, Kuhn M, et al: Expression of the melanoma cell adhesion molecule in human mesenchymal stromal cells regulates proliferation, differentiation and maintenance of hematopoietic stem and progenitor cells. Haematologica. 98:505–513. 2013. View Article : Google Scholar :
14	Chen W, Zhang HL, Jiang YG, Li JH, Liu BL, et al: Inhibition of CD146 gene expression via RNA interference reduces in vitro perineural invasion on ACC-M cell. J Oral Pathol Med. 38:198–205. 2009. View Article : Google Scholar : PubMed/NCBI
15	Xie S, Luca M, Huang S, Gutman M, Reich R, et al: Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 57:2295–2303. 1997.PubMed/NCBI
16	Malyszko J, Malyszko JS, Brzosko S, Wolczynski S and Mysliwiec M: Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab. 89:4620–4627. 2004. View Article : Google Scholar : PubMed/NCBI
17	Jiang T, Zhuang J, Duan H, Luo Y, Zeng Q, et al: CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis. Blood. 120:2330–2339. 2012. View Article : Google Scholar : PubMed/NCBI
18	Li J, Xu Y, Long XD, Wang W, Jiao HK, et al: Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity. Cancer Cell. 25:118–131. 2014. View Article : Google Scholar : PubMed/NCBI
19	Hughes JM, Groot AJ, van der Groep P, Sersansie R, Vooijs M, et al: Active HIF-1 in the normal human retina. J Histochem Cytochem. 58:247–254. 2010. View Article : Google Scholar :
20	Thompson L: World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
21	Sun ZJ, Chen G, Hu X, Zhang W, Liu Y, et al: Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: Its inhibition by quercetin. Apoptosis. 15:850–863. 2010. View Article : Google Scholar : PubMed/NCBI
22	Sun ZJ, Chen G, Zhang W, Hu X, Huang CF, et al: Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: Its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. J Pharmacol Exp Ther. 334:500–512. 2010. View Article : Google Scholar : PubMed/NCBI
23	Sun ZJ, Zhang L, Hall B, Bian Y, Gutkind JS, et al: Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. Clin Cancer Res. 18:5304–5313. 2012. View Article : Google Scholar : PubMed/NCBI
24	Welti J, Loges S, Dimmeler S and Carmeliet P: Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 123:3190–3200. 2013. View Article : Google Scholar : PubMed/NCBI
25	Kratzer A, Chu HW, Salys J, Moumen Z, Leberl M, et al: Endothelial cell adhesion molecule CD146: Implications for its role in the pathogenesis of COPD. J Pathol. 230:388–398. 2013. View Article : Google Scholar : PubMed/NCBI
26	Kebir A, Harhouri K, Guillet B, Liu JW, Foucault-Bertaud A, et al: CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivo. Circ Res. 107:66–75. 2010. View Article : Google Scholar : PubMed/NCBI
27	Ye Z, Zhang C, Tu T, Sun M, Liu D, et al: Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension. Nat Commun. 4:28032013. View Article : Google Scholar : PubMed/NCBI
28	Wang P, Luo Y, Duan H, Xing S, Zhang J, et al: MicroRNA 329 suppresses angiogenesis by targeting CD146. Mol Cell Biol. 33:3689–3699. 2013. View Article : Google Scholar : PubMed/NCBI
29	Bu P, Gao L, Zhuang J, Feng J, Yang D, et al: Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation. Mol Cancer Ther. 5:2872–2878. 2006. View Article : Google Scholar : PubMed/NCBI
30	Suzuki M, Shinohara F and Rikiishi H: Zebularine-induced reduction in VEGF secretion by HIF-1α degradation in oral squamous cell carcinoma. Mol Med Rep. 1:465–471. 2008.PubMed/NCBI
31	Zhu C, Liu X, Wang S, Yan X, Tang Z, et al: Hepatitis C virus core protein induces hypoxia-inducible factor 1α-mediated vascular endothelial growth factor expression in Huh751 cells. Mol Med Rep. 9:2010–2014. 2014.PubMed/NCBI
32	Secades P, de Santa-María IS, Merlo A, Suarez C and Chiara MD: In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy. Head Neck. May 2–2014.Epub ahead of print.
33	Lu H, Liang K, Lu Y and Fan Z: The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1α. Cancer Lett. 322:78–85. 2012. View Article : Google Scholar : PubMed/NCBI
34	Whelan KA, Schwab LP, Karakashev SV, Franchetti L, Johannes GJ, et al: The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance. J Biol Chem. 288:15865–15877. 2013. View Article : Google Scholar : PubMed/NCBI
35	Yarden Y and Pines G: The ERBB network: At last, cancer therapy meets systems biology. Nat Rev Cancer. 12:553–563. 2012. View Article : Google Scholar : PubMed/NCBI
36	Sequeiros-Santiago G, García-Carracedo D, Fresno MF, Suarez C, Rodrigo JP, et al: Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands. Oncol Rep. 21:1215–1222. 2009.PubMed/NCBI
37	Vered M, Braunstein E and Buchner A: Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck. 24:632–636. 2002. View Article : Google Scholar : PubMed/NCBI
38	Jia J, Zhang W, Liu JY, Chen G, Liu H, et al: Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma. PLoS One. 7:e515492012. View Article : Google Scholar : PubMed/NCBI